Category
Bromperidol
CAS Number
Bromperidol Decanoate STD -75067-66-2:IMP-B-NA : IMP-D-NA : IMP-F-NA : IMP-J-NA : IMP-K-NA
Molecular Formula
Bromperidol Decanoate STD -C31H41BrFNO3:IMP-B-C31H41BrFNO3 : IMP-D-C42H54Br2N2O4 : IMP-F-C37H46FNO3 : IMP-J-C32H43BrFNO3 : IMP-K-C33H45BrFNO3
Molecular Weight
Bromperidol Decanoate STD -574.58g/mol:IMP-B-574.58 g/mol : IMP-D-810.71 g/mol : IMP-F-571.78 g/mol : IMP-J-588.6 g/mol : IMP-K-602.63 g/mol
Synonym

Bromperidol Decanoate - 4-(4-Bromophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl decanoate ;

Bromperidol Decanoate EP Impurity B - 4-(4-Bromophenyl)-1-[4-(2-fluorophenyl)-4-oxobutyl]-piperidin-4-yl decanoate;

Bromperidol Decanoate EP Impurity D - 4-(4-Bromophenyl)-1-[4-[4-[4-(4-bromophenyl)-4-hydroxypiperidin-1-yl]phenyl]-4-oxobutyl]piperidin-4-yl decanoate;

Bromperidol Decanoate EP Impurity F- 4-(Biphenyl-4-yl)-1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl decanoate ; 4-([1,1'-Biphenyl]-4-yl)-1-(4-(4-fluorophenyl)-4-oxobutyl)piperidin-4-yl decanoate;

Bromperidol Decanoate EP Impurity J - 4-(4-Bromophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl undecanoate;

 Bromperidol Decanoate EP Impurity K - 4-(4-Bromophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl dodecanoate;

Slide_1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Bromperidol Decanoate System Suitability CRS is used as a reference standard to ensure the accuracy and reliability of analytical methods in quality control of bromperidol formulations. It supports system suitability testing, method validation, and compliance with pharmacopeial and regulatory standards.